Type 2 hypersensitivity is an immune reaction in which your body produces antibodies that mistakenly target the surface of your own cells or tissues, leading to their destruction. It is one of four categories of hypersensitivity reactions originally described by immunologists Gell and Coombs, and it underlies a surprisingly wide range of conditions, from transfusion reactions to autoimmune thyroid disease.
How the Reaction Works
In a normal immune response, your body makes antibodies to tag foreign invaders like bacteria or viruses for destruction. In type 2 hypersensitivity, two specific types of antibodies (IgG and IgM) bind to antigens that are sitting on the surface of your own cells or embedded in the tissue between cells. The immune system treats those tagged cells as threats and launches an attack.
Once antibodies latch onto a cell’s surface, damage happens through three main pathways. First, the antibodies activate a chain of proteins called the complement system, which punches holes in the cell membrane and destroys it directly. Second, the antibody coating acts like a “eat me” signal, a process called opsonization, that attracts immune cells to engulf and digest the tagged cell. Third, certain immune cells like natural killer cells can recognize the antibody coating and kill the target cell on contact, without needing to swallow it. All three pathways can operate at the same time, and the result is the same: the targeted cells are damaged or destroyed.
When Antibodies Block or Overstimulate Receptors
Not every type 2 reaction involves outright cell destruction. In some cases, antibodies bind to receptors on a cell’s surface and either block or overactivate them, disrupting normal function without killing the cell itself.
Myasthenia gravis is a clear example of the blocking version. Antibodies attach to the receptors that nerve signals use to tell muscles to contract. With those receptors blocked, the signal can’t get through, and the result is progressive muscle weakness that often starts in the eyelids and face before spreading to other muscles.
Graves’ disease works in the opposite direction. Antibodies bind to receptors on the thyroid gland and mimic the hormone that normally tells it to produce thyroid hormones. The thyroid responds by overproducing hormones constantly, leading to weight loss, rapid heartbeat, anxiety, and heat intolerance. In both conditions, the core problem is the same: antibodies locking onto cell-surface receptors and changing how the cell behaves.
Hemolytic Disease of the Newborn
One of the most well-known type 2 reactions occurs during pregnancy when a mother and baby have incompatible blood types, particularly involving the Rh factor. If an Rh-negative mother carries an Rh-positive baby, small amounts of fetal blood can enter her circulation during delivery. Her immune system recognizes the Rh protein as foreign and begins producing antibodies against it.
The first pregnancy is usually unaffected because the initial antibodies produced are IgM, which are too large to cross the placenta. The danger comes with subsequent pregnancies. If the next baby is also Rh-positive, the mother’s immune system rapidly produces IgG antibodies, which are small enough to cross the placenta. These antibodies bind to the baby’s red blood cells and destroy them, causing anemia that can range from mild to life-threatening. This is why Rh-negative mothers are given a preventive injection during and after pregnancy to stop the initial sensitization from ever happening.
Common Conditions Linked to Type 2 Reactions
The list of diseases driven by type 2 hypersensitivity is broad, spanning multiple organ systems:
- Autoimmune hemolytic anemia: antibodies target your own red blood cells, causing them to be destroyed faster than your body can replace them.
- Immune thrombocytopenia: antibodies attack platelets, the cells responsible for blood clotting, leading to easy bruising and prolonged bleeding.
- Goodpasture syndrome: antibodies target the membranes in the kidneys and lungs, causing kidney damage and bleeding into the lungs.
- Rheumatic fever: antibodies made against streptococcal bacteria cross-react with proteins in the heart, joints, and brain, triggering inflammation in those tissues.
- Graves’ disease: stimulating antibodies cause thyroid overactivity.
- Myasthenia gravis: blocking antibodies impair nerve-to-muscle signaling.
- Transfusion reactions: if you receive blood from an incompatible donor, your antibodies attack the transfused red blood cells.
Other conditions associated with this pathway include systemic lupus erythematosus, Sjögren’s syndrome, dermatomyositis, and graft-versus-host disease. In each case, the underlying pattern is the same: antibodies binding to cell surfaces or tissue structures and triggering an immune attack.
How Type 2 Differs From Other Hypersensitivity Reactions
The four types of hypersensitivity are often confused because they overlap in some of the diseases they cause. The key distinction for type 2 is that antibodies target antigens fixed in place, either on a cell’s surface or in the surrounding tissue matrix. Type 3 hypersensitivity also involves antibodies, but those antibodies bind to free-floating (soluble) antigens in the bloodstream. The resulting antibody-antigen clumps circulate through the body and deposit in organs that filter a lot of blood, like the kidneys and joints, causing inflammation wherever they land.
Type 1 hypersensitivity is the classic allergic reaction (think peanut allergies or hay fever), driven by a different antibody class called IgE and involving mast cells that release histamine. Type 4 doesn’t involve antibodies at all. It’s driven directly by immune cells and takes 48 to 72 hours to develop, which is why it’s called a delayed-type reaction. The tuberculosis skin test is a common example.
Type 2 reactions typically develop over hours rather than minutes, placing them between the immediate response of type 1 and the delayed response of type 4.
How Type 2 Reactions Are Diagnosed
When a type 2 reaction is suspected, particularly one involving red blood cells, the Coombs test is the go-to diagnostic tool. It comes in two forms. The direct version checks whether antibodies or complement proteins are already stuck to your red blood cells, which would indicate an ongoing immune attack. The indirect version tests your blood serum to see if it contains antibodies that react against a panel of donor red blood cells, which is important for screening before transfusions and during pregnancy.
Beyond the Coombs test, diagnosis depends on the specific condition. Blood counts showing unexplained drops in red blood cells or platelets may point toward antibody-mediated destruction. Testing for specific autoantibodies, like those against thyroid receptors in Graves’ disease or against the acetylcholine receptor in myasthenia gravis, helps confirm the diagnosis. In conditions like Goodpasture syndrome, a tissue biopsy can reveal the characteristic pattern of antibodies deposited along the membrane of the affected organ.